Actos Lawsuit Update: Doctor Group Sours on Actos in Favor of Older Diabetes Meds

Further developments in the Actos lawsuit as the medical community appears to be growing cautious of Actos (Pioglitazone), Takeda Pharmaceutical’s best selling type-2 diabetes drug. Nearly a year after the U.S. Food & Drug Administration (FDA) and other regulators worldwide warned that Actos might be associated with an increased risk of bladder cancer, at least one U.S. doctor group has cautioned patients against it.

Last month, the American College of Physicians advised that patients steer clear of expensive, new diabetes drugs like Actos, and opt instead for more “tried and true” medications such as generic metformin. A new brochure put out by the College in cooperation with Consumer Reports points out that not only is generic metformin less expensive than Actos and other newer drugs, “it lowers blood sugar levels more than newer drugs do.” It also reduces “bad cholesterol,” while newer medications don’t.

Risks of Actos Bladder Cancer

Actos Bladder Cancer Lawsuit Update

Actos Bladder Cancer Lawsuit Update

Actos, made by Takeda Pharmaceuticals, is one of the best selling type-2 diabetes drugs in the world. But June of 2011, the FDA, as well as regulators in Europe and Canada, warned that studies had shown that long-term use of Actos can increase the risk of bladder cancer by as much as 40%. New warnings were added to the U.S. and Canadian labels for Actos. In France, however, the drug was actually recalled.

Since the Actos bladder cancer warnings were issued, Actos has been named in an avalanche of U.S. lawsuits. Some legal experts say Takeda may face as many as 10,000 claims over bladder cancer and other Actos side effects. Late last year, federal Actos lawsuits were consolidated in a multidistrict litigation and transferred to Louisiana. The case is known as In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).

About the Defective Drug Attorneys of Gilman Law LLP

Gilman Law LLP, a leading national law firm, represents victims of Actos side effects, including bladder cancer. Find out more about the Actos Lawsuit on our website for the Actos Bladder Cancer Lawsuit. If you or a loved one were injured by Actos, please contact our firm as follows for a free consultation and Actos Case Review:

Contact an Actos Bladder Cancer Attorney for an Actos Lawsuit

This entry was posted in Drug Defect Lawsuits and tagged , , , , . Bookmark the permalink.

Awards & Recognition

Gilman Law LLP and its attorneys have been recognized by the leading legal publications and are listed in:


Avvo Rating
Life Member, Multi-Million Dollar Advocates Forum
Life Member, Million Dollar Advocates Forum
Super Lawyers
Lexis Nexis
LawDragon
Association of Trial Lawyers of America
Massachusetts Association of Woman's Lawyers
American Association of Justice: Leaders Forum
American Bar Association and Member of the ABA Antitrust and Litigation Sections and Forum on Franchising and Litigation Section
Public Investors Arbitration Bar Association